medigraphic.com
SPANISH

Revista Cubana de Tecnología de la Salud

ISSN 2218-6719 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 2

<< Back Next >>

Rev Cub de Tec de la Sal 2014; 5 (2)

Behavior of the breast fibroquistic changes at the '10 de Octubre hospital'

López RCM
Full text How to cite this article

Language: Spanish
References: 7
Page: 1-8
PDF size: 189.89 Kb.


Key words:

breast fibroquistic changes, non-proliferative disease of breast, benign mammary disease.

ABSTRACT

Introduction: The fribroquistic changes of the breast are one of the most frequently causes in consultation. Objective: To determine the main aspects in the breast fribroquistic changes. Methodological design: It was carried out an observational, descriptive, longitudinal and retrospective study in the Group of Mastology of the Surgical Clinical Educational Hospital 10 de Octubre, in the period from January to December 2012. The population was constituted by 56 patients whom were applied the inclusion and exclusion criterions. The sample coincided with the population. Results: The highest quantity of patients were found between 28 and 37 years old (41.0%). The most used medication was Danazol (33.9%). Most of the patients did not need surgical treatment (60.7%). The evolution was satisfactory in most of the cases. Conclusions: The breast fribroquistic changes were more frequently found in fertile ages of life. The most used medication was Danazol. The evolution of the patients was satisfactory.


REFERENCES

  1. Hayat MJ, Howlader N, Reichman ME, Edwards BK, et al. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Bethesda, Maryland: AlphaMed Press; 2007 [cited 2011 Sept 29]. Available from: http://www.seer.cancer.gov/html/.

  2. Rodríguez A, Afecciones benignas de la mama. La Habana, 2010. a p 22-24.

  3. Harris JR, Lippman ME, Morrow N, Osborne CK. Diseases of the breast. Philadelphia: Lippincott Williams & Wilkins; 2004; 9: 73-93

  4. Jekel J, Elmore J, Katz D. Epidemiology, biostatistics and preventive medicine. Mass Medical Soc. 2th ed. Philadelphia: Harcourt Health Sciences; 2010. 327:728-731.

  5. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer. 2007; 109:180-187.

  6. Cheng J, Qiu S, Raju U, Wolman SR, Worsham MJ. Benign breast disease heterogeneity: association with histopathology, age, and ethnicity. Breast Cancer Res Treat. 2007; 25:315-325.

  7. Elmore JG, Gigerenzer G. Benign Breast Disease. The Risks of Communicating Risk. N Engl J Med. 2009; 353:297-299.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub de Tec de la Sal. 2014;5